Describe the purpose of the  DRG system, Include the designations of without complications/comorbidity, with complication/comorbidity, and with major complications/comorbidity and how they affect reimbursement.

Describe primary risk factors for thromboembolic disorders? Explain how laboratory testing of coagulation parameters is used to monitor anticoagulant pharmacotherapy? Describe the nurse's role in the pharmacologic management of patients with coagulation disorders? Describe the physiology of hematopoiesis and how it can be modified by the administration of pharmacologic drugs? Explain the function of erythropoietin? Describe the nurse's role in the pharmacologic management of hematopoietic disorders?

Explain in detail the pathogenesis of a DVT (Deep Vein Thrombosis) and how it can lead to a PE (Pulmonary Embolism)

Discuss the role of anticoagulant therapy in preventing thromboembolic events.

explain why NSAIDs such as aspirin and others should be used with care

Describe the management of a patient with a tracheostomy.

A 42-year-old obese client with complaints of severe radiating chest pain, tightening in the chest, and dyspnea has received a diagnosis of angina pectoris. He is prescribed nitroglycerin tablets to relieve the pain attacks. During a follow-up visit, the client tells the nurse that the frequency and duration of the attacks have reduced with the use of nitroglycerin tablets, and now he is eager to take necessary precautions. The client is also a heavy smoker.a.    Why would you say that the client has angina pectoris and not myocardial infarction? b.    What instructions should the nurse give the client to prevent further attacks?     11, 12, 132. A 50-year-old stockbroker has recovered from coronary artery bypass grafting (CABG) surgery and is soon to be discharged. He is concerned about possible risks of coronary artery disease (CAD) and wants to lead a healthier lifestyle. What instructions should a nurse give to the client to prevent further CAD?    3. A client is scheduled for an…

Describe the difference between anticoagulants, antiplatelets, and fibrinolytics (thrombolytics). Name some of the common drugs in the anticoagulants and antiplatelets categories.

Describe the modifiable and nonmodifiable risk factors for cardiovascular disease and methods of prevention

What is the rationale for a blood transfusion in a pediatric patient with Sickle Cell Disease?